Journal
CLINICAL INFECTIOUS DISEASES
Volume 50, Issue 12, Pages E73-E76Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/653011
Keywords
-
Categories
Ask authors/readers for more resources
Temozolomide chemotherapy has become part of the therapy used to treat glioblastoma multiforme and refractory anaplastic astrocytoma. Temozolomide frequently produces profound lymphopenia. We report 2 cases of cytomegalovirus disease that occurred in patients receiving temozolomide therapy and review 4 additional cases reported in the literature. Narrow monitoring with cytomegalovirus antigenemia assay should be considered for recommendation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available